Therapeutic strategies for the prevention and treatment of cytomegalovirus infection. - Wikidata - awgldk - TriplyDB

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

http://www.wikidata.org/entity/Q38014916

about

Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Controlling the HIV/AIDS epidemic: current status and global challenges Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update.Virus-specific T-cell therapy in solid organ transplantation.Immunotherapy for transplantation-associated viral infections.Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis.Combination therapy for multidrug-resistant cytomegalovirus disease.Immune parameters to consider when choosing T-cell receptors for therapy.Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation.

P2860

Q27002575-575A1B66-3907-424F-9C40-93552D03CA4E Q30420558-2B959FE3-CC58-4FD4-BC25-5C9AC285C592 Q35156297-2C71D434-9B1F-4F97-9478-50E74BCB3C64 Q35693349-CB0E9ED2-DE69-4AF9-97B1-BE480AF4982D Q38117268-EB5D5914-23AD-437B-95A1-45D05442D9A3 Q38206823-9FA6C721-E12F-46F5-820E-50010F4218BB Q38568902-A3973A12-93E3-495F-9A5E-64AEF51CDACA Q39382670-5D63930F-91E7-4246-BF3A-E052A55BCAE2 Q39963095-1BBD01E6-A46E-418F-B816-F69F8DC76FA2 Q40968263-D5098D02-8A9C-4D7D-825A-52E2F81CA7B5 Q42129294-AADF3AEF-279E-47D5-B87C-E09EC9640C5E Q42278604-DA1F6B59-620B-40A5-8B5B-127E17D43145 Q48905387-554F584D-D3BD-4DEA-9803-947AAEECDB33

P2860

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

http://www.wikidata.org/entity/Q38014916

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

@en

type

label

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

@en

prefLabel

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

@en

P1433

Q38014916-A39E9240-A619-43B4-8D90-43E801E732F6

P1476

Q38014916-E644E7AC-373D-4D56-93BB-FFC5C1C0ECDA

P2093

Q38014916-6F2578A6-28CC-4AC2-8E98-8D6C20A8B6A8

Q38014916-F38E044B-6AEF-4D1A-88E3-667FB726BC4D

P2860

Q38014916-0647F90F-753D-4BF0-8879-97D724B4E188

Q38014916-08EAD4E6-6E21-4E25-A69D-43A41858F7F5

Q38014916-09A9D04F-E28C-40F1-B69E-82A3E7B959C1

Q38014916-0A6F538A-1F3C-4F6F-B3BC-563370DC3C50

Q38014916-0D16FC24-DA14-442C-A650-311B9E7F5722

Q38014916-0E4DE927-B860-4E7B-A05C-7CEF1B48C723

Q38014916-18F94EB9-6B42-41B8-A48B-40D79EB75293

Q38014916-2B6C1CB6-4D67-4F2A-9F36-23E08C2C0369

Q38014916-2EEBB89E-8468-463E-83B9-29DF5A46A227

Q38014916-2FEA774C-D339-4DBE-ABAA-C896BBDF2D8C

P304

Q38014916-05E0AC8E-9224-4C20-A3C4-7834ED646747

P31

Q38014916-4383B18A-5613-4FB0-9CA5-8AB8EAB9BF94

P356

Q38014916-C84EED7B-C82E-41B8-AF68-D0637488C146

P407

Q38014916-F36285D6-23F1-4704-9903-4EC818CFFC62

P433

Q38014916-208BDF55-A529-4489-B3DD-C1FE1205E060

P478

Q38014916-4F857056-A6D2-4557-A579-492B0A455E1C

P577

Q38014916-4C682E68-0342-4D00-A11A-6EF41BE441A0

P698

Q38014916-53300459-79D3-4ACC-9154-B4643DA55BE3

P921

Q38014916-8C20474A-48BA-4273-980C-DB0EA74EE1E0

P356

14712598.2012.693471

P1433

Expert Opinion on Biological Therapy

P1476

Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.

@en

P2093

Karl S Peggs

http://www.w3.org/2001/XMLSchema#string

Rob S Sellar

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.

Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.

Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.

P304

1161-1172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2012.693471

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22650422

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus